Full Text View
Tabular View
No Study Results Posted
Related Studies
Antiepileptic Drugs and Vascular Risk Markers
This study is currently recruiting participants.
Verified August 2010 by Thomas Jefferson University
Study NCT00774306   Information provided by Thomas Jefferson University

First Received on October 16, 2008.   Last Updated on August 17, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Subarachnoid Hemorrhage
Additional conditions recognized in this trial
Hemorrhage
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Intracranial Hemorrhages
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
phenytoin
valproate
levetiracetam
Additional drug interventions recognized in this trial
Anticonvulsants
Etiracetam
Piracetam
Valproic Acid
More general drug interventions related to this trial
Antimanic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
GABA Agents
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Nootropic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Thomas Jefferson University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services